MiRNA-based stem cell therapy for Myocardial disorders: MiRNA-421 enhances Mesenchymal stem cell therapy for Myocardial infarction via suppression of its target gene, 31/July/2014, 5.14 am

Molecular therapy for human cancer: Tanshinone IIA suppresses the expression of FGFR1 via up regulation of its target gene, 31/July/2014, 5.07 am
July 30, 2014
MiRNA-based therapy for Gastic carcinoma: Tumor suppressor p53 homologue TAp63 inhibits gastric cell metastasis via down regulation of OPN (Osteopontin), 31/July/2014, 5.18 am
July 30, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan,  L., MiRNA-based stem cell therapy for Myocardial disorders: MiRNA-421 enhances Mesenchymal stem  cell therapy for Myocardial infarction via suppression of its target gene, 31/July/2014, 5.14 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.